My Work ( Legalization of Marijuana in South Carolina)

Pain Relief Coming Soon

Who Am I?

My name is Michael Fogarty. My work towards legalization of marijuana in South Carolina is the focus of my blogging here. I am no one in particular. I am an American citizen living currently in the state of South Carolina. I will write to you my history that has brought me to the point in my life to where I am now fighting for us all in South Carolina with the need for a better pain reliever, medical cure, and complete natural therapy that is grown from the Earth as God intended.

Pain is Relative in the End
Nothing is Impossible

Read more

My Diary Part 1: Life of a Chronic Pain Sufferer

Trapped in Pain

Day 1

Day one of this diary  of  the life of a chronic pain sufferer is the beginning of a journey between you and me that we will take together. It will be a journey of understanding, education and hopefully will bring to the forefront some compassion and change to the minds of those that did not see what happens to those that do have life long chronic pain. While it is easy to hear that someone suffers with chronic pain or that someone is a chronic pain sufferer, it isn’t always easy to put yourself in the other person’s shoes so to speak. With these diary entries in the next coming weeks, I hope to introduce to you, the readers, the insider’s point of view to being a chronic pain sufferer from someone that has been a chronic pain sufferer for over 28 long miserable painful years. 

Read more

MMJ BioScience Developing New Multiple Sclerosis Drug- From Cannabis Plant To Pharmaceutical

medical marijuana multiple sclerosis

MMJ International Holdings, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research and operation of medical cannabis healthcare businesses, today announced that its affiliate MMJ Bioscience, is developing the first pharmaceutical formulation of cannabidiol (CBD) derived from certain extracts of the cannabis plant. MMJ BioScience is also currently beginning Phase 2 studies with a new drug for the treatment of primary progressive multiple sclerosis.

Read more

Item added to cart.
0 items - $0.00